Cargando…
The efficacy of betulinic acid in triple-negative breast cancer
PURPOSE: The treatment of triple-negative breast cancer remains a daunting challenge with the standard-of-care treatments eventually failing due to acquired drug resistance, toxic side effects and the presence of a deregulated immune response. New treatments for overcoming these drawbacks include th...
Autores principales: | Weber, Daniel, Zhang, Mixia, Zhuang, Pengwei, Zhang, Yanjun, Wheat, Janelle, Currie, Geoffrey, Al-Eisawi, Zaynab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607226/ https://www.ncbi.nlm.nih.gov/pubmed/26770742 http://dx.doi.org/10.1177/2050312114551974 |
Ejemplares similares
-
Role of betulinic acid derivative SH-479 in triple negative breast cancer and bone microenvironment
por: Tang, Liang, et al.
Publicado: (2021) -
Neural correlates of negative emotion processing in subthreshold depression
por: Zhang, Shu, et al.
Publicado: (2022) -
Pharmacokinetic Considerations for Digoxin in Older People
por: Currie, Geoffrey M, et al.
Publicado: (2011) -
Efficacy of chemotherapy after hormone therapy for hormone receptor–positive metastatic breast cancer
por: Mori, Ryutaro, et al.
Publicado: (2014) -
Direct Stimulation of Adult Neural Stem/Progenitor Cells In Vitro and Neurogenesis In Vivo by Salvianolic Acid B
por: Zhuang, Pengwei, et al.
Publicado: (2012)